Author: Hu, Aimin; Li, Junyu; Ruan, Shufang; Fan, Ying; Liao, Yuqian
Title: Polymorphisms in CLDN1 are associated with age and differentiation of triple-negative breast cancer patients Document date: 2019_4_23
ID: 106tex7s_7
Snippet: Statistical analysis was performed using SPSS version 18.0 (SPSS Inc, Chicago, IL, U.S.A.). The distribution of genotypes in patients with different clinicopathological characteristics was compared by two-sided Pearson's χ 2 tests, odds ratios (ORs) and 95% confidence intervals (CI) were calculated by logistic regression. Disease-free survival (DFS) was calculated from date of diagnosis to date of first locoregional recurrence, first distant met.....
Document: Statistical analysis was performed using SPSS version 18.0 (SPSS Inc, Chicago, IL, U.S.A.). The distribution of genotypes in patients with different clinicopathological characteristics was compared by two-sided Pearson's χ 2 tests, odds ratios (ORs) and 95% confidence intervals (CI) were calculated by logistic regression. Disease-free survival (DFS) was calculated from date of diagnosis to date of first locoregional recurrence, first distant metastasis, or death from any cause (whichever came first). Overall survival (OS) was calculated from date of diagnosis to date of death from any reason or last follow-up. Kaplan-Meier curves with the log-rank test were applied to estimate and compare 5-year DFS and OS rates of patients with different genotypes. Hazard ratios (HR) of recurrence/metastasis and death with 95% CI were estimated by Cox-regression model. The multivariate analysis was adjusted for age, histological grade, tumor size, lymph node status, and vascular invasion. All statistical tests were two-sided, and P<0.05 was considered significant.
Search related documents:
Co phrase search for related documents- log rank test and lymph node status: 1
- log rank test and multivariate analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- log rank test and node status: 1
- log rank test and os overall survival: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- log rank test and overall survival: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55
- log rank test and recurrence metastasis: 1, 2
- log rank test and SPSS version: 1, 2, 3, 4
- log rank test Kaplan Meier curve and logistic regression: 1, 2, 3
- log rank test Kaplan Meier curve and multivariate analysis: 1
- log rank test Kaplan Meier curve and overall survival: 1, 2
- log rank test Kaplan Meier curve and statistical analysis: 1
- significant consider and SPSS version: 1
- significant consider and statistical analysis: 1, 2, 3
- SPSS version and statistical analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77
- SPSS version and statistical test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- statistical analysis and tumor size: 1, 2, 3, 4, 5, 6, 7
- statistical analysis and vascular invasion: 1
- tumor size and vascular invasion: 1, 2, 3, 4, 5, 6, 7, 8
- tumor size and vascular invasion lymph node status: 1
Co phrase search for related documents, hyperlinks ordered by date